Bottom line
FACDX vs QAAGZX: the short answer
FACDX (Fidelity Advisor Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 47% by weight.
QAAGZX is cheaper at 0.86% vs 0.96% — a difference of $10.00 a year per $10,000 invested.
Over five years, QAAGZX returned +4.1% a year vs +2.3% for FACDX (reporting dates differ).
Updated Nov 19, 2026
FACDX vs QAAGZX side by side
| FACDX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.96% | 0.86% |
| Annual cost per $10k | $96 | $86 |
| 10-yr cost on $10k (prospectus) | $1,685 | $1,061 |
| Max front load | — | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +7.7% | +18.1% |
| 5-yr return (annualized) | +2.3% | +4.1% |
| 10-yr return (annualized) | +7.6% | +9.0% |
| Best quarter | +21.3% | +23.4% |
| Worst quarter | −15.0% | −15.8% |
| Net assets (fund) | $3.1B | $751.7M |
| Number of holdings | 154 | 277 |
| Portfolio turnover | 74% | 65% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FACDX | QAAGZX | Difference |
|---|---|---|---|
| 2025 | +14.2% | +18.1% | −3.9% |
| 2024 | +3.9% | +1.7% | +2.2% |
| 2023 | +3.8% | +3.0% | +0.9% |
| 2022 | −13.1% | −12.5% | −0.6% |
| 2021 | +11.2% | +13.1% | −1.9% |
| 2020 | +21.1% | +29.6% | −8.5% |
| 2019 | +27.9% | +29.0% | −1.1% |
| 2018 | +7.3% | +1.1% | +6.2% |
| 2017 | +24.1% | +27.6% | −3.5% |
| 2016 | −10.3% | −10.5% | +0.2% |
Source: Fund prospectus bar charts
Holdings overlap
11 of FACDX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | FACDX | QAAGZX |
|---|---|---|
| ELI LILLY and CO | 7.66% | 14.06% |
| Danaher Corp | 6.75% | 1.44% |
| Thermo Fisher Scientific Inc | 6.31% | 2.53% |
| Unitedhealth Group Inc | 4.17% | 5.88% |
| JOHNSON and JOHNSON | 3.78% | 6.64% |
| Abbvie Inc | 3.62% | 5.12% |
| MERCK and CO INC | 2.09% | 4.00% |
| Natera Inc | 1.65% | 1.44% |
| Guardant Health Inc | 1.48% | 1.22% |
| Cvs Health Corp | 1.29% | 0.93% |
| Gilead Sciences Inc | 1.25% | 2.79% |
Source: SEC Form N-PORT
FACDX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between FACDX and QAAGZX?
Which is cheaper, FACDX or QAAGZX?
Should I own both FACDX and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.